肿胀膝盖治疗市场规模、份额和成长分析：按类型、最终用户和地区划分 - 行业预测，2024-2031 年

肿胀膝盖治疗市场规模将于 2022 年达到 20 亿美元，从 2023 年的 20.9 亿美元增长到 2031 年的 29.7 亿美元，预测期（2024-2031）预计将以 4.5% 的复合年增长率增长。

由于向非手术医疗保健的显着转变，肿胀的膝盖治疗市场可能会在其成长轨迹中遇到障碍。这一趋势反映出人们普遍偏好微创和非侵入性治疗，相对于传统手术更青睐治疗方式。人们越来越意识到与膝关节置换术等手术相关的潜在风险和併发症，这有助于患者偏好的改变。人们越来越多地寻求具有可比功效的替代品，同时降低风险并缩短恢復时间。

目录

介绍

• 这项研究的目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 技术分析
• 价值链分析
• 价格分析
• Start-Ups分析
• 监管环境
• 专利分析
• 管道分析
• 关键成功因素
• 市场吸引力指数
• 竞争程度
• 关键投资机会
• 生态系绘图

肿胀的膝盖治疗市场：按类型

• 市场概况
• 药品
• 病人自控镇痛泵
• 神经阻断
• 布比卡因Bupivacaine
• 外科手术

膝盖肿胀治疗市场：依医药产品分类

• 市场概况
• 阿片类药物
• 皮质类固醇
• 其他的

膝盖肿胀治疗市场：透过手术

• 市场概况
• 关节穿刺术
• 关节镜
• 关节重建置换术
  • 全膝关节置换术
  • 单间室膝关节关节重建
  • 其他的

肿胀的膝盖治疗市场：按最终用户分类

• 市场概况
• 医院
• 指定诊所
• 门诊手术中心
• 其他的

按地区分類的膝盖肿胀治疗市场规模

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Pfizer Inc.（United States）
• Johnson & Johnson（United States）
• Novartis AG（Switzerland）
• GlaxoSmithKline plc（United Kingdom）
• Merck & Co., Inc.（United States）
• Bayer AG（Germany）
• Sanofi（France）
• Eli Lilly and Company（United States）
• Abbott Laboratories（United States）
• AstraZeneca plc（United Kingdom）
• Bristol-Myers Squibb Company（United States）
• Boehringer Ingelheim GmbH（Germany）
• AbbVie Inc.（United States）
• Amgen Inc.（United States）
• F. Hoffmann-La Roche AG（Switzerland）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Mylan NV（United States）
• Novo Nordisk A/S（Denmark）
• Allergan plc（United States）
• Takeda Pharmaceutical Company Limited（Japan）

Swollen Knee Treatment Market size was valued at USD 2.00 billion in 2022 and is poised to grow from USD 2.09 billion in 2023 to USD 2.97 billion by 2031, growing at a CAGR of 4.5% in the forecast period (2024-2031).

The swollen knee treatment market might encounter obstacles in its growth path due to a noticeable shift towards non-surgical healthcare options. This trend advocates for healing modalities over traditional surgery, reflecting a broader preference for less invasive and non-invasive treatments. Heightened awareness of potential risks and complications linked to procedures like knee arthroplasty contributes to this change in patient preferences. People are increasingly seeking alternatives that offer comparable efficacy with reduced risks and shorter recovery periods.

Top-down and bottom-up approaches were used to estimate and validate the size of the Swollen Knee Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Swollen Knee Treatment Market Segmental Analysis

The swollen knee treatment market is segmented based on type, end user, and region. Based on type, the market is segmented into Medications (Opioids, Corticosteroids, Others), Patient-controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine, Surgery (Arthrocentesis, Arthroscopy, Knee Replacement). Based on end user, the market is segmented into hospitals, designated clinics, ambulatory surgical centers, and others. Based on region, the swollen knee treatment market is segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

Drivers of the Swollen Knee Treatment Market

The escalating healthcare expenses in the market create substantial prospects for enhancing accessibility, innovation, and efficiency within the dental care industry. Improved income distribution enables better healthcare services, cutting-edge technology, and enhanced medical treatments. However, to fully capitalize on these opportunities, it is crucial to tackle challenges such as uneven distribution, ethical considerations, and financial viability. Implementing appropriate and well-planned sustainability measures is essential to ensure that increased healthcare expenditure benefits all segments of the population, thereby reducing disparities in access to dental care.

Restraints in the Swollen Knee Treatment Market

Advanced medical procedures like knee replacement surgery often pose financial obstacles that restrict access for patients with limited resources. The expenses related to knee replacement surgery encompass various elements such as preoperative assessments, surgical techniques, postoperative care, and rehabilitation, making access to this beneficial treatment limited. The financial challenges associated with advanced procedures like knee replacement surgery highlight the significance of addressing healthcare disparities and ensuring equitable access to treatment for all.

Market Trends of the Swollen Knee Treatment Market

Ongoing advancements in medical device technology, particularly in knee-related solutions, offer significant opportunities for innovative therapeutic approaches to tackle orthopedic conditions. Innovations in knee braces and assistive devices mark a new era in medical solutions, enhancing patient comfort and optimizing treatment outcomes. These modern devices are engineered to deliver precise, stable, and reliable support for a spectrum of knee-related issues, spanning from injuries to chronic conditions. This evolution supports healthcare professionals in tailoring interventions according to the unique needs of each patient, thereby advancing personalized treatment options.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Pricing Analysis
• Start Up Analysis
• Regulatory Landscape
• Patent Analysis
• Pipeline Analysis
• Key Success Factors
• Market Attractiveness Index
• Degree of Competition
• Top Investment Pockets
• Ecosystem Mapping

Swollen Knee Treatment Market by Type

• Market Overview
• Medications
• Patient-controlled Analgesia Pumps
• Nerve Blocks
• Liposomal Bupivacaine
• Surgery

Swollen Knee Treatment Market by Medications

• Market Overview
• Opioids
• Corticosteroids
• Others

Swollen Knee Treatment Market by Surgery

• Market Overview
• Arthrocentesis
• Arthroscopy
• Knee Replacement
  • Total Knee Replacement
  • Unicompartmental Knee Replacement
  • Others

Swollen Knee Treatment Market by End User

• Market Overview
• Hospitals
• Designated Clinics
• Ambulatory Surgical Centers
• Others

Swollen Knee Treatment Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol-Myers Squibb Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan plc (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments